|
|||||
![]() |
|
Beauty, cosmetics, and personal care retailer Ulta Beauty (NASDAQ:ULTA) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.3% year on year to $2.79 billion. The company’s full-year revenue guidance of $12.05 billion at the midpoint came in 2.8% above analysts’ estimates. Its GAAP profit of $5.78 per share was 14.6% above analysts’ consensus estimates.
Is now the time to buy ULTA? Find out in our full research report (it’s free).
Ulta delivered a well-received second quarter, surpassing Wall Street’s expectations on both revenue and earnings. Management attributed this outperformance to robust growth in core categories, effective promotional strategies, and the ongoing traction of the Ulta Beauty Unleashed strategy. CEO Kecia Steelman highlighted that the company’s “comp sales growth of 6.7% was driven by balanced contribution from newness and core assortment growth,” emphasizing strong performance in fragrance, skincare, and loyalty membership expansion. Ulta also benefited from operational improvements, including lower inventory shrink and enhanced in-store execution, which contributed to improved margins and guest satisfaction.
Looking ahead, Ulta’s raised full-year outlook is supported by continued momentum in core categories, a strong pipeline of exclusive brand launches, and the initial benefits of international expansion. Management remains cautious due to macroeconomic uncertainty and evolving consumer spending patterns, but is confident that strategic investments in digital and new business initiatives will sustain growth. As Steelman noted, “We remain focused on controlling what we can control, executing our plans with excellence, and building on our momentum to drive future growth.” The company expects further gains from its wellness and digital personalization efforts, while carefully monitoring competitive pressures and promotional discipline.
Management pointed to several business drivers behind Ulta’s Q2 performance, with a focus on category strength, marketing execution, and operational improvements.
Ulta’s guidance for the remainder of the year is shaped by ongoing strength in core categories, strategic investments, and disciplined cost management amid a dynamic retail environment.
Looking ahead, the StockStory team is closely monitoring (1) the ramp-up and performance of Ulta’s new online marketplace and exclusive brand launches, (2) the integration and growth of Space NK in the U.K. and the opening of new stores in Mexico and the Middle East, and (3) the sustainability of margin improvements amid cost pressures and evolving promotional dynamics. Execution on digital innovation and wellness category expansion will also be key markers of progress.
Ulta currently trades at $552.50, up from $530.29 just before the earnings. Is the company at an inflection point that warrants a buy or sell? See for yourself in our full research report (it’s free).
Donald Trump’s April 2025 "Liberation Day" tariffs sent markets into a tailspin, but stocks have since rebounded strongly, proving that knee-jerk reactions often create the best buying opportunities.
The smart money is already positioning for the next leg up. Don’t miss out on the recovery - check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Oct-22 | |
Oct-22 | |
Oct-21 | |
Oct-20 | |
Oct-17 | |
Oct-17 | |
Oct-16 | |
Oct-16 | |
Oct-16 | |
Oct-16 | |
Oct-16 | |
Oct-16 | |
Oct-15 | |
Oct-14 | |
Oct-14 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite